Q32 Bio Inc.

NASDAQ:QTTB

Biotechnology

Healthcare
$8.48 -1.70%

-$0.22 today

Market cap
$253.75M
Beta
-0.23
P/E (TTM)
5.4
EPS (TTM)
$2.36
52W Low $1.35High $14.85

Volume 0.31M

Average 0.74M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$33.54M

FY 2025 · Annual

Investing Cash Flow

$7.00M

FY 2025 · Annual

-64.9% YoY

Financing Cash Flow

-$3.13M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(95.76M)(42.81M)(53.74M)(47.73M)29.82M
Depreciation & Amortization9.54M370K499K487K391K
Deferred Income Tax02.43M000
Stock-Based Compensation01.24M1.43M4.39M5.26M
Change in Working Capital(41.8M)26.94M26.32M(9.64M)(4.04M)
Accounts Receivables00000
Inventory00000
Accounts Payables(2.49M)(1.24M)2.03M(1.04M)(2.11M)
Other Working Capital(39.32M)28.18M24.28M(8.59M)(1.93M)
Other Non-Cash Items18.27M876K6.82M(15.22M)(64.97M)
Operating Cash Flow(109.75M)(10.96M)(18.68M)(67.72M)(33.54M)
Capital Expenditures(2.4M)(2.49M)(5K)(75K)0
Acquisitions (Net)0130M000
Purchases of Investments(97.39M)(157.46M)000
Sales of Investments49M65.46M020M0
Other Investing Activities0(37.98M)007M
Investing Cash Flow(50.79M)(2.47M)(5K)19.93M7M
Debt Repayment030M300K7M(3.13M)
Common Stock Issued52.17M69K106K42M0
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities00046.14M0
Financing Cash Flow52.17M30.07M406K95.14M(3.13M)
Effect of Forex Changes(679K)09.91M00
Net Change in Cash(109.05M)16.65M(8.37M)47.35M(29.67M)
Free Cash Flow(112.15M)(13.44M)(18.68M)(67.79M)(33.54M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$29.8M
+ D&A$391.0K
+ Stock-Based Comp$5.3M
+ Deferred Tax$0
- Working Capital-$4.0M
- Other Non-Cash-$65.0M
= Operating Cash Flow-$33.5M
- Capex$0
= Free Cash Flow-$33.5M

Analysis

FY2025 free cash flow is -$33.5M. FCF conversion is -112.5% of net income. Operating cash flow was -$33.5M, with capex of $0. The largest bridge item is Other Non-Cash at -$65.0M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 6, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
SC 13GSC 13G filingOct 28, 2026

Does QTTB generate free cash flow?

Q32 Bio Inc. (QTTB) generated -$33.54M of free cash flow in fiscal 2025.

How much operating cash flow does QTTB produce?

Operating cash flow was -$33.54M, before capital expenditures of $0.00.